PANE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 977
NA - Nord America 735
AS - Asia 415
SA - Sud America 30
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.175
Nazione #
US - Stati Uniti d'America 718
RU - Federazione Russa 472
IT - Italia 283
SG - Singapore 185
HK - Hong Kong 111
CN - Cina 77
NL - Olanda 55
DE - Germania 42
IE - Irlanda 27
BR - Brasile 25
FI - Finlandia 22
GB - Regno Unito 19
IN - India 14
CA - Canada 13
FR - Francia 13
CI - Costa d'Avorio 12
BG - Bulgaria 11
UA - Ucraina 7
AT - Austria 6
KR - Corea 6
MK - Macedonia 5
CH - Svizzera 4
JP - Giappone 4
PH - Filippine 4
SE - Svezia 4
TR - Turchia 4
VN - Vietnam 4
BE - Belgio 3
MX - Messico 3
ZA - Sudafrica 3
BD - Bangladesh 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
HN - Honduras 1
IR - Iran 1
MA - Marocco 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 2.175
Città #
Chandler 143
Moscow 126
Hong Kong 111
Singapore 96
Ashburn 73
Santa Clara 54
Naples 44
Amsterdam 41
Seattle 27
Millbury 26
Beijing 25
Nanjing 24
Dearborn 18
Des Moines 18
Napoli 17
Princeton 16
Milan 13
Nola 13
Boston 12
Hefei 11
Sofia 11
Lawrence 10
Norwalk 10
Rome 10
Helsinki 9
Toronto 9
Cava De' Tirreni 8
Dublin 8
Gricignano di Aversa 7
Le Cannet 7
Wilmington 7
Pune 6
Seoul 6
Falkenstein 5
London 5
Monteforte Irpino 5
Padova 5
Afragola 4
Columbus 4
Dong Ket 4
Fairfield 4
Frankfurt am Main 4
Izmir 4
Latina 4
Lviv 4
Nuremberg 4
Ottawa 4
Redwood City 4
Torre Annunziata 4
Turin 4
Washington 4
Barcellona Pozzo di Gotto 3
Battipaglia 3
Bitola 3
Brussels 3
Dallas 3
Düsseldorf 3
General Mariano Alvarez 3
Houston 3
Montecorvino Pugliano 3
São Paulo 3
Verona 3
Vienna 3
Acerra 2
Brusciano 2
Caruaru 2
Davis 2
Florence 2
Formia 2
Marano di Napoli 2
Marsala 2
Monza 2
Munich 2
Parma 2
Phoenix 2
Pisa 2
Pompei 2
Portici 2
Portsmouth 2
Sassari 2
Secunderabad 2
Shenyang 2
Skopje 2
South Jordan 2
The Dalles 2
Tianjin 2
Whitby 2
Abu Dhabi 1
Aleksandrów Kujawski 1
Amaral Ferrador 1
Ampére 1
Asunción 1
Atlanta 1
Baku 1
Belo Horizonte 1
Bern 1
Boa Esperança 1
Boardman 1
Boqueirão 1
Capua 1
Totale 1.189
Nome #
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 87
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 84
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response 81
The use of medical-grade cannabis in patients non-responders to Nabiximols 80
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection 80
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 80
Prevalence and features of non-motor symptoms in Wilson's disease 77
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 75
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 75
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 74
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 73
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 72
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 71
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 69
Peripheral markers of autophagy in polyglutamine diseases 69
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 68
A randomized clinical trial of lithium in multiple system atrophy. 67
Adult normative values for the PATA Rate Test 66
Mobitz type I and II atrioventricular blocks during fingolimod therapy 64
Fingolimod first dose safety in clinical practice. 58
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 57
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 57
Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia 57
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review 55
The Multiple Faces of Spinocerebellar Ataxia type 2 52
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 51
Othello syndrome in Parkinson's disease: a systematic review and report of a case series 51
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 50
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial 48
Dissociative Identity Disorder: Restoration of Executive Functions After Switch from Alter to Host Personality. 48
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 45
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A 36
The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series 35
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis 27
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group 24
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients 24
null 23
Gradient of microstructural damage along the dentato‐thalamo‐cortical tract in Friedreich ataxia 22
Nonvascular Parkinsonism in Fabry Disease: Results from Magnetic Resonance and Dopamine Transporter Imaging 19
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes. 17
Totale 2.268
Categoria #
all - tutte 9.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.047


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 0 0 14 1
2020/202142 5 0 1 9 0 4 2 2 8 0 6 5
2021/2022188 3 6 1 1 5 10 6 5 31 13 37 70
2022/2023344 36 37 13 19 40 33 9 28 58 52 16 3
2023/2024256 7 33 17 21 14 25 13 55 7 2 32 30
2024/20251.155 51 31 9 30 63 63 163 94 95 121 435 0
Totale 2.268